BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 7088025)

  • 1. [Antimycotic sensitivity of clinically important yeasts and moulds in the agar diffusion method (author's transl)].
    Dermoumi H
    Mykosen; 1982 Mar; 25(3):109-17. PubMed ID: 7088025
    [No Abstract]   [Full Text] [Related]  

  • 2. [Antimycotic sensitivity of yeast-like fungi isolated from HIV-infected patients].
    Polishchuk OI; Pokas OV; Vialykh ZhE; Vasylenko LH; Koltukova NV
    Mikrobiol Z; 2007; 69(3):37-43. PubMed ID: 17682529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Susceptibility testing of clinical important yeasts--comparison of agar dilution technique and agar diffusion technique (author's transl)].
    Dermoumi H
    Mykosen; 1980 Jan; 23(1):1-9. PubMed ID: 7383052
    [No Abstract]   [Full Text] [Related]  

  • 4. [A phenomenon of "growth stimulation" of yeasts tested for sensitivity to polyenes in the agar diffusion test].
    Müller HJ; Weber A
    Mykosen; 1984 Oct; 27(10):511-3. PubMed ID: 6440017
    [No Abstract]   [Full Text] [Related]  

  • 5. [Testing the sensitivity of opportunistic agents of mycoses to antimycotic drugs in vitro].
    Otcenásek M; Buchta V
    Cesk Epidemiol Mikrobiol Imunol; 1993 Mar; 42(1):29-34. PubMed ID: 8485769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro antifungal susceptibility methods and clinical implications of antifungal resistance.
    Espinel-Ingroff A; Warnock DW; Vazquez JA; Arthington-Skaggs BA
    Med Mycol; 2000; 38 Suppl 1():293-304. PubMed ID: 11204157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Has a decade of standardizing antifungal sensitivity tests accomplished anything?].
    Rodríguez Tudela JL; Cuenca Estrella M
    Enferm Infecc Microbiol Clin; 2002 May; 20(5):191-3. PubMed ID: 12006254
    [No Abstract]   [Full Text] [Related]  

  • 8. Susceptibility of Mexican isolates of yeasts and moulds to amphotericin B and triazole antifungals.
    Arredondo-García JL; Amábile-Cuevas CF;
    J Infect Dev Ctries; 2009 Jun; 3(5):398-401. PubMed ID: 19759511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reliability of the WIDERYST susceptibility testing system for detection of in vitro antifungal resistance in yeasts.
    Cuenca-Estrella M; Gomez-Lopez A; Gutierrez MO; Buitrago MJ; Rodriguez-Tudela JL
    Antimicrob Agents Chemother; 2008 Mar; 52(3):1062-5. PubMed ID: 18195057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro antifungal activity of aminosterols against moulds isolated from cystic fibrosis patients.
    Alhanout K; Brunel JM; Ranque S; Rolain JM
    J Antimicrob Chemother; 2010 Jun; 65(6):1307-9. PubMed ID: 20335187
    [No Abstract]   [Full Text] [Related]  

  • 11. [Experimental study of the antifungal effect of phenylmercuric borate. I. In vitro study].
    Grigoriu D; Grigoriu A
    Mykosen; 1969 Mar; 12(3):167-76. PubMed ID: 5397908
    [No Abstract]   [Full Text] [Related]  

  • 12. Antifungal sensitivity testing for equine keratomycosis.
    Coad CT; Robinson NM; Wilhelmus KR
    Am J Vet Res; 1985 Mar; 46(3):676-8. PubMed ID: 3994133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Standardization of antifungal susceptibility testing and clinical relevance.
    Espinel-Ingroff A; Barchiesi F; Hazen KC; Martinez-Suarez JV; Scalise G
    Med Mycol; 1998; 36 Suppl 1():68-78. PubMed ID: 9988494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of disk diffusion test and Etest for voriconazole and fluconazole susceptibility testing.
    Buchta V; Vejsova M; Vale-Silva LA
    Folia Microbiol (Praha); 2008; 53(2):153-60. PubMed ID: 18837162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro susceptibility of non-Aspergillus allergenic fungal species to azoles.
    Duddy NE; Moore CB; Howard SJ; Denning DW
    J Antimicrob Chemother; 2009 Apr; 63(4):834-6. PubMed ID: 19221103
    [No Abstract]   [Full Text] [Related]  

  • 16. In vitro activity of voriconazole against yeasts, moulds and dermatophytes in comparison with fluconazole, amphotericin B and griseofulvin.
    Wildfeuer A; Seidl HP; Paule I; Haberreiter A
    Arzneimittelforschung; 1997 Nov; 47(11):1257-63. PubMed ID: 9428984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Susceptibility of fungi isolated from clinical materials to voriconazole].
    Pawlik B; Szul A; Macura AB
    Med Dosw Mikrobiol; 2006; 58(2):155-61. PubMed ID: 17133909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Current status of studies on sensitivity to antifungal agents].
    Martín Mazuelos E
    Enferm Infecc Microbiol Clin; 1992; 10(6):366-71. PubMed ID: 1391021
    [No Abstract]   [Full Text] [Related]  

  • 19. In vitro interactions of itraconazole and micafungin against clinically important filamentous fungi.
    Ruíz-Cendoya M; Rodriguez MM; Mariné M; Pastor FJ; Guarro J
    Int J Antimicrob Agents; 2008 Nov; 32(5):418-20. PubMed ID: 18762407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical relevance of resistance to antifungals.
    Rodriguez-Tudela JL; Alcazar-Fuoli L; Cuesta I; Alastruey-Izquierdo A; Monzon A; Mellado E; Cuenca-Estrella M
    Int J Antimicrob Agents; 2008 Nov; 32 Suppl 2():S111-3. PubMed ID: 19013333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.